TNBC	Triple negative breast cancer
CIC	Cancer initiating cell
RIT	Radioimmunotherapy
CSPG4	Chondroitin sulfate proteoglycan 4
mAb	Monoclonal antibody
RIC	Radioimmunoconjugate
HER-2	Human epidermal growth factor receptor 2
LET	Linear energy transfer
keV	Kiloelectron volt
i.v.	Intravenous
HPGe	High purity germanium
TCMC	2-(4-isothiocyanotobenzyl)-1,4,7,10-tetraaza-1,4,7,10-tetra-(2-carbamoylmethyl)-cyclododecane
EDTA	Ethylene diaminetetraacetic acid
ITLC	Instant thin layer chromatography
ANOVA	Analysis of variance
RES	Reticuloendothelial system